Clinical Trials Browser

Phase 2 × Turcot syndrome × 90 days × Clear all

NCT03607890 2026-03-16

Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor

Phase 2 Active not recruiting

Turcot syndrome, Microsatellite Instability

NCT04104893 2026-02-27

CHOMP

Phase 2 Active not recruiting

Turcot syndrome, Prostatic Neoplasms

NCT03767348 2026-02-13

IGNYTE

Phase 2 Active not recruiting

DermatologicThoracic

Turcot syndrome, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT07403877 2026-02-11

TORCH-OPTIMA

Phase 2 Not yet recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT07369986 2026-01-27

IMMUNE-SAVE

Phase 2 Not yet recruiting

Turcot syndrome, Endometrial Neoplasms

NCT03228667 2026-01-14

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

Phase 2 Active not recruiting

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Microsatellite Instability, Small Cell Lung Carcinoma

NCT07259473 2026-01-07

Pre-CATALIS

Phase 2 Not yet recruiting

Turcot syndrome